The Board denied the Veteran's claims for service connection for MGUS and CVID, finding that there was no evidence linking these conditions to his in-service benzene exposure. The Board also found that the conditions were not present during active military service or within one year of discharge.
The deciding factor: There is no competent medical evidence showing a direct relationship between the Veteran's current MGUS and CVID diagnoses and his presumed in-service benzene exposure, as well as no evidence linking these conditions to his period of active duty.
- Claimed conditions
- Monoclonal gammopathy of undetermined significance (MGUS), Common variable immune deficiency (CVID)
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- November 3, 2011
- Citation
- 1140956
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 1140956.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Denied
The Veteran's claim for a compensable rating for monoclonal gammopathy of undetermined significance (MGUS) is denied. The claim for service connection for bone cancer is also denied.
- Whole decision: Remanded (sent back)
The Board has decided to remand the claims for MGUS and right knee disability due to a lack of examinations, which may provide additional evidence on the etiology of these conditions.
- Whole decision: Denied
The Veteran's service-connected monoclonal gammopathy of undetermined significance (MGUS) has not manifested to symptomatic multiple myeloma, and thus does not warrant a compensable rating.
- Whole decision: Remanded (sent back)
The Board has remanded the case for a medical opinion regarding whether the Veteran's MGUS is related to herbicide agent exposure, and also for a determination on an initial compensable rating for MGUS.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.